• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Clinical Trials

Pharma & Human Health

MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study

June 14, 2018 Microbiome Times

4D pharma plc announced that the Company has received clearance from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Products Regulatory Authority (HPRA) to commence the Phase II study of Blautix, the […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • Using a novel computational approach, researchers confirm microbial diversity is wilder than ever.
    October 30, 2023
  • Pharmacomicrobiomics: The universe of microbiome-drug interactions
    October 26, 2023
  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
sign up

Sign up to the Microbiome Times newsletterÂ